Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model

Anti-tumor drugs can effectively shrink the lesions of primary lung cancer; however, it has limited therapeutic effect on patients with brain metastasis (BM). A BM preclinical model based on a multi-organ microfluidic chip has been established proficiently in our previous work. In this study, the BM...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mingxin, Wang, Yingyan, Duan, Wenzhe, Xia, Shengkai, Wei, Song, Liu, Wenwen, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783320/
https://www.ncbi.nlm.nih.gov/pubmed/33415100
http://dx.doi.org/10.3389/fbioe.2020.612091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783320/
https://www.ncbi.nlm.nih.gov/pubmed/33415100
http://dx.doi.org/10.3389/fbioe.2020.612091

Ejemplares similares